Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 1, 2019
Patent Application Number
15326444
Date Filed
July 16, 2015
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Human cytomegalovirus vectors comprising heterologous antigens are disclosed. The vectors derived from the TR strain, are ganciclovir-sensitive, include active US2, US3, US6, US7 and UL131A genes, and have a deleterious or inactivating mutation in the UL82 gene preventing the expression of pp71.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
